loading
Schlusskurs vom Vortag:
$0.962
Offen:
$0.95
24-Stunden-Volumen:
68,096
Relative Volume:
0.55
Marktkapitalisierung:
$3.98M
Einnahmen:
$502.40K
Nettoeinkommen (Verlust:
$-7.91M
KGV:
-0.0943
EPS:
-9.972
Netto-Cashflow:
$-4.32M
1W Leistung:
-7.84%
1M Leistung:
-26.56%
6M Leistung:
-66.31%
1J Leistung:
-90.36%
1-Tages-Spanne:
Value
$0.91
$0.98
1-Wochen-Bereich:
Value
$0.91
$1.04
52-Wochen-Spanne:
Value
$0.85
$12.45

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name
Firmenname
60 Degrees Pharmaceuticals Inc
Name
Telefon
202-327-5422
Name
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Name
Mitarbeiter
3
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-15
Name
Neueste SEC-Einreichungen
Name
SXTP's Discussions on Twitter

Vergleichen Sie SXTP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SXTP
60 Degrees Pharmaceuticals Inc
0.94 4.07M 502.40K -7.91M -4.32M -9.972
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.64 110.88B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
726.21 72.79B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
890.11 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
404.46 54.85B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
189.85 41.41B 447.02M -1.18B -906.14M -6.1812

60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten

pulisher
Dec 08, 2025

Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22 - Daytona Beach News-Journal

Dec 08, 2025
pulisher
Dec 07, 2025

60 Degrees Pharmaceuticals Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis

Dec 07, 2025
pulisher
Dec 07, 2025

Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Leesburg Daily Commercial

Dec 07, 2025
pulisher
Dec 06, 2025

Gains Report: Can 60 Degrees Pharmaceuticals Inc stock maintain growth trajectory2025 Analyst Calls & Technical Pattern Based Signals - BỘ NỘI VỤ

Dec 06, 2025
pulisher
Dec 05, 2025

Day Trade: Why 60 Degrees Pharmaceuticals Inc stock is considered a top pickJuly 2025 Rallies & Stock Portfolio Risk Management - BỘ NỘI VỤ

Dec 05, 2025
pulisher
Dec 04, 2025

Can 60 Degrees Pharmaceuticals Inc. stock maintain growth trajectoryMarket Trend Review & Daily Stock Momentum Reports - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Is 60 Degrees Pharmaceuticals Inc Equity Warrant a good long term investmentReal-Time Stock Alerts & Rapid Capital Trading Tips - earlytimes.in

Dec 03, 2025
pulisher
Nov 30, 2025

Will 60 Degrees Pharmaceuticals Inc. stock deliver long term returnsNew Guidance & Weekly Breakout Opportunity Watchlist - BỘ NỘI VỤ

Nov 30, 2025
pulisher
Nov 30, 2025

What You Should Know About Kohinoor Foods Limiteds Profitability RatiosMarket Volatility Update & Small Investment Portfolio - earlytimes.in

Nov 30, 2025
pulisher
Nov 29, 2025

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given New $2.80 Price Target at Ascendiant Capital Markets - Defense World

Nov 29, 2025
pulisher
Nov 28, 2025

Why 60 Degrees Pharmaceuticals Inc. stock is considered a top pickLayoff News & Smart Swing Trading Alerts - BỘ NỘI VỤ

Nov 28, 2025
pulisher
Nov 28, 2025

Dick's Sporting Goods To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

Nov 28, 2025
pulisher
Nov 28, 2025

Ascendiant Capital Maintains 60 Degrees Pharmaceuticals (SXTP) Buy Recommendation - Nasdaq

Nov 28, 2025
pulisher
Nov 27, 2025

Is 60 Degrees Pharmaceuticals Inc. stock a defensive play in 20252025 Top Gainers & Capital Efficient Trading Techniques - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 26, 2025

How 60 Degrees Pharmaceuticals Inc. stock reacts to job market dataMarket Performance Report & Daily Stock Trend Watchlist - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 21, 2025

60 Degrees Pharmaceuticals Inc. (SXTP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharma begins enrollment for chronic babesiosis study By Investing.com - Investing.com Nigeria

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharma begins enrollment for chronic babesiosis study - Investing.com India

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharmaceuticals announces clinical site now open for patient enrollment - MarketScreener

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharmaceuticals Launches First-Ever Study for Tafenoquine in Chronic Babesiosis Patients - Quiver Quantitative

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine - The Manila Times

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharmaceuticals Announces Clinical Site Now Open - GlobeNewswire

Nov 21, 2025
pulisher
Nov 21, 2025

Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock reach all time highs in 2025 - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How resilient is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock in market downturnsPortfolio Return Report & Low Volatility Stock Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is 60 Degrees Pharmaceuticals Inc. stock supported by innovation pipeline2025 Support & Resistance & Growth Focused Stock Pick Reports - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Upgraded at Zacks Research - Defense World

Nov 21, 2025
pulisher
Nov 20, 2025

How 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performs in high volatility markets2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will 60 Degrees Pharmaceuticals Inc. Equity Warrant see short term momentumPortfolio Update Report & High Yield Stock Recommendations - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock sustain free cash flow growthJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is 60 Degrees Pharmaceuticals Inc. stock oversold or undervaluedPortfolio Risk Summary & Safe Capital Allocation Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will 60 Degrees Pharmaceuticals Inc. stock attract more institutional investors2025 Volatility Report & Expert Curated Trade Setups - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What technical charts say about 60 Degrees Pharmaceuticals Inc. Equity Warrant stockWeekly Trade Recap & Weekly Breakout Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock maintain operating margins2025 Trading Volume Trends & Safe Entry Zone Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail

Nov 19, 2025
pulisher
Nov 19, 2025

How to integrate 60 Degrees Pharmaceuticals Inc. Equity Warrant into portfolio analysis toolsSell Signal & AI Enhanced Trade Execution Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

60 Degrees Pharmaceuticals Faces Financial Challenges Amid Growth Efforts - MSN

Nov 19, 2025

Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$38.26
price up icon 0.45%
$95.17
price up icon 0.01%
$31.24
price up icon 1.00%
$95.73
price down icon 0.12%
biotechnology ONC
$322.68
price up icon 1.25%
$189.85
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):